|
|
|
|
|
|
|
|
Comments |
|
20
|
108
|
Type 2N
|
2560C>T
|
R854W
|
No
|
Wales
|
|
The mutation creates a restriction site for BsrI.
|
Bowen et al., 1998
|
28
|
10
|
Type 2M
|
4273A>T
|
I1425F
|
Yes
|
USA
|
Montgomery
|
VWF:RCo = 4-13, VWF:Ag = 13-36, normal collagen binding, normal multimers
|
Hillery et al, 1998
|
Deletion exons 22-43
|
6
|
Type 3
|
Not Determined
|
Null Allele
|
No
|
USA
|
Sadler
|
Deletion associated with inhibitory antibody formation to VWF.
|
Mancuso et al., 1994
|
12
|
10
|
Type 2A
|
1309-1326del
|
D437-R442del
|
Yes
|
USA
|
Montgomery
|
VWF from abnormal allele has no ristocetin and low botrocetin binding to platele More ...
|
|
31
|
6
|
Type 2M
|
5356C>G
|
H1786D
|
Yes
|
USA
|
Montgomery, ZPMCB-VWD
|
The mutation results in defective binding to both type I and type III collagen.
|
Flood et al., 2010
|
28
|
4
|
Type 2A
|
4735G>A
|
G1579R
|
No
|
USA
|
Robert Montgomery
|
|
|
28
|
20
|
Type 2M
|
4173-4205 del
|
R1392-Q1402 del
|
Yes
|
USA
|
Montgomery
|
VWF:RCo = 3-8, VWF:Ag 14-35, normal multimers, no platelet binding with ristocet More ...
|
Mancuso et al, 1996
|
52
|
2
|
Unclassified
|
8416T>C
|
C2806R
|
Yes
|
USA
|
Montgomery
|
VWF:RCo <12 U/dl, VWF:Ag 30 U/dl, 1 band on multimer gel
|
|
28
|
2
|
Type 2B
|
3916C>T
|
R1306W
|
No
|
USA
|
Montgomery
|
|
|
Deletion exons 33-38
|
6
|
Type 3
|
5621-269_6799-1161del
|
Null Allele
|
No
|
USA
|
Sadler
|
Deletion associated with inhibitory antibody formation to VWF.
|
Mancuso et al., 1994
|